These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11789675

  • 1. In vivo applications of PEG liposomes: unexpected observations.
    Laverman P, Boerman OC, Oyen WJG, Corstens FHM, Storm G.
    Crit Rev Ther Drug Carrier Syst; 2001; 18(6):551-66. PubMed ID: 11789675
    [Abstract] [Full Text] [Related]

  • 2. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
    Laverman P, Carstens MG, Boerman OC, Dams ET, Oyen WJ, van Rooijen N, Corstens FH, Storm G.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
    [Abstract] [Full Text] [Related]

  • 3. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C, Wang C, Yang H, Zhao X, Wei N, Cui J.
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [Abstract] [Full Text] [Related]

  • 4. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.
    Laverman P, Brouwers AH, Dams ET, Oyen WJ, Storm G, van Rooijen N, Corstens FH, Boerman OC.
    J Pharmacol Exp Ther; 2000 Jun; 293(3):996-1001. PubMed ID: 10869403
    [Abstract] [Full Text] [Related]

  • 5. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T, Atobe K, Wang X, Kiwada H.
    J Control Release; 2006 Oct 27; 115(3):251-8. PubMed ID: 17045355
    [Abstract] [Full Text] [Related]

  • 6. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
    Ishida T, Kiwada H.
    Int J Pharm; 2008 Apr 16; 354(1-2):56-62. PubMed ID: 18083313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
    Wang X, Ishida T, Kiwada H.
    J Control Release; 2007 Jun 04; 119(2):236-44. PubMed ID: 17399838
    [Abstract] [Full Text] [Related]

  • 10. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, Wang SJ, Liu RS, Lin WJ, Yang CS, Ting G.
    Anticancer Res; 2009 Jun 04; 29(6):2111-20. PubMed ID: 19528471
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid.
    Semple SC, Harasym TO, Clow KA, Ansell SM, Klimuk SK, Hope MJ.
    J Pharmacol Exp Ther; 2005 Mar 04; 312(3):1020-6. PubMed ID: 15525796
    [Abstract] [Full Text] [Related]

  • 13. Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study.
    Underwood C, van Eps AW, Ross MW, Laverman P, van Bloois L, Storm G, Schaer TP.
    Equine Vet J; 2012 Mar 04; 44(2):196-202. PubMed ID: 21696436
    [Abstract] [Full Text] [Related]

  • 14. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.
    Wang XY, Ishida T, Ichihara M, Kiwada H.
    J Control Release; 2005 May 05; 104(1):91-102. PubMed ID: 15866337
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration.
    Romberg B, Oussoren C, Snel CJ, Carstens MG, Hennink WE, Storm G.
    Biochim Biophys Acta; 2007 Mar 05; 1768(3):737-43. PubMed ID: 17223070
    [Abstract] [Full Text] [Related]

  • 16. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
    Ishida T, Ichihara M, Wang X, Kiwada H.
    J Control Release; 2006 Oct 27; 115(3):243-50. PubMed ID: 17011060
    [Abstract] [Full Text] [Related]

  • 17. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor.
    Abu Lila AS, Doi Y, Nakamura K, Ishida T, Kiwada H.
    J Control Release; 2010 Mar 03; 142(2):167-73. PubMed ID: 19861140
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
    Metselaar JM, Bruin P, de Boer LW, de Vringer T, Snel C, Oussoren C, Wauben MH, Crommelin DJ, Storm G, Hennink WE.
    Bioconjug Chem; 2003 Mar 03; 14(6):1156-64. PubMed ID: 14624629
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.